Literature DB >> 23112111

Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

Joanne W Elena1, Emily Steplowski, Kai Yu, Patricia Hartge, Geoffrey S Tobias, Michelle J Brotzman, Stephen J Chanock, Rachael Z Stolzenberg-Solomon, Alan A Arslan, H Bas Bueno-de-Mesquita, Kathy Helzlsouer, Eric J Jacobs, Andrea LaCroix, Gloria Petersen, Wei Zheng, Demetrius Albanes, Naomi E Allen, Laufey Amundadottir, Ying Bao, Heiner Boeing, Marie-Christine Boutron-Ruault, Julie E Buring, J Michael Gaziano, Edward L Giovannucci, Eric J Duell, Göran Hallmans, Barbara V Howard, David J Hunter, Amy Hutchinson, Kevin B Jacobs, Charles Kooperberg, Peter Kraft, Julie B Mendelsohn, Dominique S Michaud, Domenico Palli, Lawrence S Phillips, Kim Overvad, Alpa V Patel, Leah Sansbury, Xiao-Ou Shu, Michael S Simon, Nadia Slimani, Dimitrios Trichopoulos, Kala Visvanathan, Jarmo Virtamo, Brian M Wolpin, Anne Zeleniuch-Jacquotte, Charles S Fuchs, Robert N Hoover, Myron Gross.   

Abstract

PURPOSE: Diabetes is a suspected risk factor for pancreatic cancer, but questions remain about whether it is a risk factor or a result of the disease. This study prospectively examined the association between diabetes and the risk of pancreatic adenocarcinoma in pooled data from the NCI pancreatic cancer cohort consortium (PanScan).
METHODS: The pooled data included 1,621 pancreatic adenocarcinoma cases and 1,719 matched controls from twelve cohorts using a nested case-control study design. Subjects who were diagnosed with diabetes near the time (<2 years) of pancreatic cancer diagnosis were excluded from all analyses. All analyses were adjusted for age, race, gender, study, alcohol use, smoking, BMI, and family history of pancreatic cancer.
RESULTS: Self-reported diabetes was associated with a forty percent increased risk of pancreatic cancer (OR = 1.40, 95 % CI: 1.07, 1.84). The association differed by duration of diabetes; risk was highest for those with a duration of 2-8 years (OR = 1.79, 95 % CI: 1.25, 2.55); there was no association for those with 9+ years of diabetes (OR = 1.02, 95 % CI: 0.68, 1.52).
CONCLUSIONS: These findings provide support for a relationship between diabetes and pancreatic cancer risk. The absence of association in those with the longest duration of diabetes may reflect hypoinsulinemia and warrants further investigation.

Entities:  

Mesh:

Year:  2012        PMID: 23112111      PMCID: PMC3529822          DOI: 10.1007/s10552-012-0078-8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  46 in total

1.  Implementation of the Women's Health Initiative study design.

Authors:  Garnet L Anderson; Joann Manson; Robert Wallace; Bernedine Lund; Dallas Hall; Scott Davis; Sally Shumaker; Ching-Yun Wang; Evan Stein; Ross L Prentice
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

2.  Baseline characteristics of participants in the Women's Health Study.

Authors:  K M Rexrode; I M Lee; N R Cook; C H Hennekens; J E Buring
Journal:  J Womens Health Gend Based Med       Date:  2000 Jan-Feb

Review 3.  Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.

Authors:  R A DeFronzo; E Ferrannini
Journal:  Diabetes Care       Date:  1991-03       Impact factor: 19.112

4.  Abnormal glucose metabolism and pancreatic cancer mortality.

Authors:  S M Gapstur; P H Gann; W Lowe; K Liu; L Colangelo; A Dyer
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

Review 5.  Hyper- and hypoinsulinemia in type-2 diabetes: what may be wrong in the secretory mechanism of the B-cell.

Authors:  H P Ammon
Journal:  Exp Clin Endocrinol Diabetes       Date:  1997       Impact factor: 2.949

6.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

7.  The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group.

Authors: 
Journal:  Ann Epidemiol       Date:  1994-01       Impact factor: 3.797

8.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

9.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

Authors:  J Everhart; D Wright
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272

10.  Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Authors:  V A Grote; S Rohrmann; A Nieters; L Dossus; A Tjønneland; J Halkjær; K Overvad; G Fagherazzi; M C Boutron-Ruault; S Morois; B Teucher; S Becker; D Sluik; H Boeing; A Trichopoulou; P Lagiou; D Trichopoulos; D Palli; V Pala; R Tumino; P Vineis; S Panico; L Rodríguez; E J Duell; E Molina-Montes; M Dorronsoro; J M Huerta; E Ardanaz; S M Jeurnink; J W J Beulens; P H M Peeters; M Sund; W Ye; B Lindkvist; D Johansen; K T Khaw; N Wareham; N Allen; F Crowe; M Jenab; I Romieu; D S Michaud; E Riboli; D Romaguera; H B Bueno-de-Mesquita; R Kaaks
Journal:  Diabetologia       Date:  2011-09-28       Impact factor: 10.122

View more
  40 in total

1.  Genetic variability in energy balance and pancreatic cancer risk in a population-based case-control study in Minnesota.

Authors:  Jianjun Zhang; Ishwori B Dhakal; Xuemei Zhang; Anna E Prizment; Kristin E Anderson
Journal:  Pancreas       Date:  2014-03       Impact factor: 3.327

Review 2.  Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis.

Authors:  Gundula Behrens; Carmen Jochem; Daniela Schmid; Marlen Keimling; Cristian Ricci; Michael F Leitzmann
Journal:  Eur J Epidemiol       Date:  2015-03-15       Impact factor: 8.082

Review 3.  A molecular rheostat at the interface of cancer and diabetes.

Authors:  Mahasin A Osman; Fazlul H Sarkar; Enrique Rodriguez-Boulan
Journal:  Biochim Biophys Acta       Date:  2013-04-29

4.  Editorial: Mendelian Randomization Analysis Identifies Body Mass Index and Fasting Insulin as Potential Causal Risk Factors for Pancreatic Cancer Risk.

Authors:  Konstantinos K Tsilidis; James Y Dai; Ulrike Peters
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506

5.  Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.

Authors:  Samuel O Antwi; William R Bamlet; Katrina S Pedersen; Kari G Chaffee; Harvey A Risch; Nitin Shivappa; Susan E Steck; Kristin E Anderson; Paige M Bracci; Jerry Polesel; Diego Serraino; Carlo La Vecchia; Cristina Bosetti; Donghui Li; Ann L Oberg; Alan A Arslan; Demetrius Albanes; Eric J Duell; Inge Huybrechts; Laufey T Amundadottir; Robert Hoover; Satu Mannisto; Stephen J Chanock; Wei Zheng; Xiao-Ou Shu; Magdalena Stepien; Federico Canzian; Bas Bueno-de-Mesquita; José Ramon Quirós; Anne Zeleniuch-Jacquotte; Fiona Bruinsma; Roger L Milne; Graham G Giles; James R Hébert; Rachael Z Stolzenberg-Solomon; Gloria M Petersen
Journal:  Carcinogenesis       Date:  2018-07-30       Impact factor: 4.944

6.  Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.

Authors:  Jason W Hoskins; Jinping Jia; Marta Flandez; Hemang Parikh; Wenming Xiao; Irene Collins; Mickey A Emmanuel; Abdisamad Ibrahim; John Powell; Lizhi Zhang; Nuria Malats; William R Bamlet; Gloria M Petersen; Francisco X Real; Laufey T Amundadottir
Journal:  Carcinogenesis       Date:  2014-09-18       Impact factor: 4.944

7.  Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study.

Authors:  Melissa A Austin; Elena Kuo; Stephen K Van Den Eeden; Margaret T Mandelson; Teresa A Brentnall; Aruna Kamineni; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-21       Impact factor: 4.254

8.  Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.

Authors:  C Bosetti; V Rosato; D Li; D Silverman; G M Petersen; P M Bracci; R E Neale; J Muscat; K Anderson; S Gallinger; S H Olson; A B Miller; H Bas Bueno-de-Mesquita; G Scelo; V Janout; I Holcatova; P Lagiou; D Serraino; E Lucenteforte; E Fabianova; P A Baghurst; W Zatonski; L Foretova; E Fontham; W R Bamlet; E A Holly; E Negri; M Hassan; A Prizment; M Cotterchio; S Cleary; R C Kurtz; P Maisonneuve; D Trichopoulos; J Polesel; E J Duell; P Boffetta; C La Vecchia; P Ghadirian
Journal:  Ann Oncol       Date:  2014-07-23       Impact factor: 32.976

9.  A pooled analysis of body mass index and pancreatic cancer mortality in african americans.

Authors:  Traci N Bethea; Cari M Kitahara; Jennifer Sonderman; Alpa V Patel; Chinonye Harvey; Synnøve F Knutsen; Yikyung Park; Song Yi Park; Gary E Fraser; Eric J Jacobs; Mark P Purdue; Rachael Z Stolzenberg-Solomon; Elizabeth M Gillanders; William J Blot; Julie R Palmer; Laurence N Kolonel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-13       Impact factor: 4.254

Review 10.  High risk factors of pancreatic carcinoma.

Authors:  Soriba Naby Camara; Tao Yin; Ming Yang; Xiang Li; Qiong Gong; Jing Zhou; Gang Zhao; Zhi-Yong Yang; Tajoo Aroun; Martin Kuete; Sonam Ramdany; Alpha Kabinet Camara; Aissatou Taran Diallo; Zhen Feng; Xin Ning; Jiong-Xin Xiong; Jing Tao; Qi Qin; Wei Zhou; Jing Cui; Min Huang; Yao Guo; Shan-Miao Gou; Bo Wang; Tao Liu; Ohoya Etsaka Terence Olivier; Tenin Conde; Mohamed Cisse; Aboubacar Sidiki Magassouba; Sneha Ballah; Naby Laye Moussa Keita; Ibrahima Sory Souare; Aboubacar Toure; Sadamoudou Traore; Abdoulaye Korse Balde; Namory Keita; Naby Daouda Camara; Dusabe Emmanuel; He-Shui Wu; Chun-You Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.